Trials / Completed
CompletedNCT02110004
Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the First-In-Man clinical investigation is to assess the Picasso NAV Catheter's ability to collect intracardiac signals within the desired chambers (atrial and/or ventricle) in the heart for the analysis of complex arrhythmias.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ablation procedure | The primary purpose of the First-In-Man clinical investigation is to assess the Picasso NAV Catheter's ability to collect intra-cardiac signals within the desired chambers (atrial and/or ventricle) in the heart for the analysis of complex arrhythmias. |
| DEVICE | Picasso NAV Catheter |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-10-01
- First posted
- 2014-04-10
- Last updated
- 2025-02-03
Source: ClinicalTrials.gov record NCT02110004. Inclusion in this directory is not an endorsement.